androstenedione has been researched along with abiraterone acetate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auchus, RJ; Chang, KH; Evaul, K; Li, R; Liu, J; Sharifi, N; Sharma, KK; Yoshimoto, J | 1 |
| Audenet, F; Murez, T; Neuzillet, Y; Ripert, T; Villers, A | 1 |
| Auchus, RJ; Buschur, EO; Chang, AY; Gonzalez, M; Hammer, GD; Jiao, J; Madrigal, D; Ramm, C; Smit, JW; Wang, G; Xu, XS; Yu, MK | 1 |
| Beijnen, JH; Rosing, H; van Nuland, M; van Rossum, HH; Venekamp, N; Wouters, WME | 1 |
1 review(s) available for androstenedione and abiraterone acetate
| Article | Year |
|---|---|
[CYP17A1 inhibitors in prostate cancer: mechanisms of action independent of the androgenic pathway].
Topics: Abiraterone Acetate; Adjuvants, Immunologic; Androgens; Androstadienes; Androstenedione; Antineoplastic Agents; Dehydroepiandrosterone; Disease Progression; Humans; Male; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase; Treatment Outcome | 2013 |
1 trial(s) available for androstenedione and abiraterone acetate
| Article | Year |
|---|---|
Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency.
Topics: 17-alpha-Hydroxyprogesterone; Abiraterone Acetate; Adrenal Hyperplasia, Congenital; Adult; Androgen Antagonists; Androgens; Androstadienes; Androstenedione; Androsterone; Desoxycorticosterone; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Treatment Outcome | 2014 |
2 other study(ies) available for androstenedione and abiraterone acetate
| Article | Year |
|---|---|
Abiraterone inhibits 3β-hydroxysteroid dehydrogenase: a rationale for increasing drug exposure in castration-resistant prostate cancer.
Topics: 3-Hydroxysteroid Dehydrogenases; Abiraterone Acetate; Active Transport, Cell Nucleus; Androstadienes; Androstenedione; Animals; Antineoplastic Agents; Cell Line, Tumor; Dehydroepiandrosterone; Dihydrotestosterone; Drug Resistance, Neoplasm; Humans; Isoenzymes; Male; Mice; Mice, Inbred NOD; Mice, SCID; Orchiectomy; Prostatic Neoplasms; Receptors, Androgen; Testosterone; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
LC-MS/MS assay for the quantification of testosterone, dihydrotestosterone, androstenedione, cortisol and prednisone in plasma from castrated prostate cancer patients treated with abiraterone acetate or enzalutamide.
Topics: Abiraterone Acetate; Androstenedione; Benzamides; Chromatography, Liquid; Dihydrotestosterone; Humans; Hydrocortisone; Male; Nitriles; Phenylthiohydantoin; Plasma; Prednisone; Prostatic Neoplasms, Castration-Resistant; Tandem Mass Spectrometry; Testosterone | 2019 |